Becker's Healthcare May 8, 2023
As a result of genomics being a big part of medical research in recent decades, numerous tests have passed the clinical evidence threshold into standard of care (SOC) and are reimbursed as medically necessary.
Furthering precision medicine’s impact will depend on these test penetrating routine patient care in upcoming years.
During a workshop sponsored by Illumina at Becker’s Hospital Review’s 13th Annual Meeting, experts discussed how genomics and precision medicine are rapidly evolving from a cutting-edge technology to the standard of care, particularly in oncology, genetic disease management and pharmaceutical therapies.
Illumina is an applied genomics technology company making genomics accessible for all. Since 1998, this California-based company’s mission has been to improve human health by unlocking the power of...
Today's Sponsors
Today's Sponsor